Navigation Links
Research on HIV takes new direction

A new ray of hope in AIDS research. A new set of anti-viral compounds has proved much more potent than the original in laboratory studies and opened a promising new direction in AIDS research. These related developments are described in the current tissue. Both publications are peer-reviewed journals of the American Chemical Society, the world's largest scientific society.//

The compounds, called guanidinoglycosides, are intended to prevent HIV from forming and spreading throughout the body, according to Yitzhak Tor, who led the research team at the University of Cleavland. According to him chemically modified from existing antibiotics known as aminoglycosides, the new compounds target the genetic structure of the virus essential to its replication.

Specifically, they target the "Rev" protein that is responsible for producing and spreading HIV-infected cells. Without this protein, viral cells would be unable to reproduce and the disease would be disarmed, Tor said. By working with the virus's genetics, the researchers have found a place less prone to mutations that could lead to drug resistance, he added.

According to Tor if we can use drugs that prevent Rev from creating new viral cells, the HIV genetic material becomes useless. While numerous other groups explore more traditional approaches to anti-viral therapy, we believe that certain sites - like the rev intersection site - are promising and underutilized targets for anti-HIV drug design.

Aminoglycoside antibiotics have not been used to treat HIV because of their side effects and inefficiency in preventing the spread of the virus, Tor said. Guanidino groups are more promising, he believes. But it will be years before human testing could begin. We think this is an important direction for HIV research, Tor said. We hope these compounds can inhibit the interactions that allow the HIV to spread. This area is still in the dark ages, so there's plenty of opportunity for progress.


'"/>




Related medicine news :

1. Kidney Stones - Interesting New Research implicates bacteria as its cause
2. Researchers urge caution in using ear tube surgery
3. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
4. Researchers Scale to assess the Severity of Epilepsy in Kids
5. Research of Ritalin
6. Researchers trick Alzheimers Enzyme
7. Researchers find new HIV hiding place
8. A Compilation of recent Diabetes Research articles
9. Research on causes for falling helps develop preventive strategies
10. New standards for Human Research Safety
11. Research on Celiac Disease in children
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... ... a crisis. Her son James, eight, was out of control. Prone to extreme mood shifts ... upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife ... and say he was going to kill them. If we were driving on the ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... 2016 , ... People across the U.S. are sharpening their pencils and honing ... contest in which patients and their families pay tribute to a genetic counselor by ... Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Investment Group (TGIG), has initiated cultivation and processing operations at its production facility, ... Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of proactive ...
(Date:6/24/2016)... ... 24, 2016 , ... Venture Construction Group (VCG) sponsors Luke’s Wings ... 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. ... service members that have been wounded in battle and their families. Venture Construction Group ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
(Date:6/23/2016)... -- Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... . ... ... ... Astellas is ...
(Date:6/23/2016)... 2016  Experian Health, the healthcare industry ... patient payment and care experience, today announced ... and services that will enhance the breadth ... These award-winning solutions will enable healthcare professionals ... in an ever-changing environment and redefine front-office ...
Breaking Medicine Technology: